Salvage non-myeloablative allogeneic transplantation after failure of an autologous transplantation in multiple myeloma

被引:0
|
作者
Qazilbash, MH [1 ]
Saliba, R [1 ]
Mendoza, F [1 ]
Roden, L [1 ]
Hosing, C [1 ]
Couriel, DE [1 ]
Kebriaci, W [1 ]
Popat, U [1 ]
De Lima, M [1 ]
Champlin, RE [1 ]
Giralt, SA [1 ]
机构
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词
D O I
10.1016/j.bbmt.2005.11.358
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
334
引用
收藏
页码:117 / 117
页数:1
相关论文
共 50 条
  • [41] Prognostic factors for donor lymphocyte infusions following non-myeloablative allogeneic stem cell transplantation in multiple myeloma
    N W C J van de Donk
    N Kröger
    U Hegenbart
    P Corradini
    J F San Miguel
    H Goldschmidt
    J A Perez-Simon
    M Zijlmans
    R A Raymakers
    V Montefusco
    F A Ayuk
    M H J van Oers
    A Nagler
    L F Verdonck
    H M Lokhorst
    Bone Marrow Transplantation, 2006, 37 : 1135 - 1141
  • [42] Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation Followed by Bortezomib Maintenance Therapy for High Risk Multiple Myeloma
    Green, Damian J.
    Maloney, David G.
    Storer, Barry E.
    Sandmaier, Brenda M.
    Holmberg, Leona A.
    Martin, Paul J.
    Becker, Pamela S.
    Georges, George E.
    Bouvier, Michelle E.
    Storb, Rainer
    Mielcarek, Marco B.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S215 - S215
  • [43] Allogeneic transplantation after non-myeloablative conditioning consolidation therapy following high-dose melphalan and autologous stem cell transplantation improve outcome in high-risk multiple myeloma
    Martino, M
    Beltrami, G
    Corsetti, MT
    Penna, G
    Messina, G
    Morabito, F
    Iacopino, P
    Carella, A
    BONE MARROW TRANSPLANTATION, 2004, 33 : S156 - S156
  • [44] Diffuse alveolar hemorrhage in patients undergoing non-myeloablative allogeneic stem cell transplantation after prior autologous/syngeneic transplantation.
    Lin, TS
    Molina, A
    Penza, SL
    Farag, SS
    Avalos, BR
    Grever, MR
    Copelan, EA
    Byrd, JC
    BLOOD, 2002, 100 (11) : 432B - 432B
  • [45] Progressive disease after non-myeloablative allogeneic stem cell transplantation.
    Bolwell, BJ
    Pohlman, B
    Sobecks, R
    Andresen, S
    Theil, KS
    Brown, S
    Bernhard, L
    Curtis, J
    Koennecke, J
    Kosar, J
    Ostendorf, H
    Sands, K
    Serafin, M
    Kalaycio, M
    BLOOD, 2002, 100 (11) : 634A - 634A
  • [46] Second autologous or allogeneic transplantation after the failure of first autograft in patients with multiple myeloma
    Qazilbash, MH
    Saliba, R
    De Lima, M
    Hosing, C
    Couriel, D
    Aleman, A
    Roden, L
    Champlin, R
    Giralt, SA
    CANCER, 2006, 106 (05) : 1084 - 1089
  • [47] Second autologous or allogeneic transplantation after the failure of first autograft in multiple myeloma.
    Qazilbash, MH
    Saliba, R
    de Lima, M
    Couriel, D
    Hosing, C
    Aleman, A
    Lei, X
    Champlin, RE
    Giralt, SA
    BLOOD, 2004, 104 (11) : 909A - 909A
  • [48] Immune recovery after conventional and non-myeloablative allogeneic stem cell transplantation
    Schulenburg, A
    Fischer, M
    Kalhs, P
    Mitterbauer, M
    Rabitsch, W
    Greinix, HT
    Leitner, G
    LEUKEMIA & LYMPHOMA, 2005, 46 (12) : 1755 - 1760
  • [49] Chronic but not acute graft-versus-host disease improves outcome in multiple myeloma patients after non-myeloablative allogeneic transplantation
    Pérez-Simón, JA
    Martino, R
    Alegre, A
    Tomás, JF
    De Leon, A
    Caballero, D
    Sureda, A
    Sierra, J
    San Miguel, JF
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 121 (01) : 104 - 108
  • [50] High-dose melphalan and autologous stem cell transplantation followed by non-myeloablative conditioning regime and allogeneic stem cell transplantation as consolidation therapy in multiple Myeloma.
    Schneider, P
    Fenk, R
    Bernhardt, A
    Rohr, U
    Till, E
    Wehmeier, A
    Haas, R
    Kobbe, G
    BLOOD, 2001, 98 (11) : 351B - 351B